Back to announcement
20240729_EPMT_Laporan Informasi dan Fakta Material_31688576.pdf
Other Text extracted EPMTSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat L595/EPMT/CSEC/VII/2024
Nama Perusahaan Enseval Putera Megatrading Tbk
Kode Emiten EPMT
Lampiran 2
Penyampaian informasi sehubungan dengan penandatanganan Shareholders
Perihal
Agreement (SHA) dalam rangka pendirian perusahaan patungan bernama PT
Livzon Pharma Indonesia.
Dengan ini kami untuk dan atas nama perusahaan menyampaikan Laporan Informasi atau Fakta Material sebagai
berikut:
Nama Emiten atau Perusahaan Publik Enseval Putera Megatrading Tbk
Bidang Usaha Distributor Produk Kesehatan
Telepon (021) 46822422
Faksimili (021) 460 9039
Alamat Surat Elektronik (email) investor.relations@enseval.com
Tanggal Kejadian 29 Juli 2024
Jenis Informasi atau Fakta Material Penyampaian informasi sehubungan dengan
penandatanganan Shareholders Agreement (SHA) dalam
rangka pendirian perusahaan patungan bernama PT Livzon
Pharma Indonesia.
Uraian Informasi atau Fakta Material Dalam rangka memenuhi Peraturan Otoritas Jasa Keuangan
No. 31/POJK.04/2015 tanggal 16 Desember 2015 tentang
Keterbukaan atas Informasi atau Fakta Material oleh Emiten
atau Perusahaan Publik, Perusahaan menyampaikan bahwa:
a. Perusahaan melalui anak usahanya, PT Global
Chemindo Megatrading (GCM) bersama dengan Lian SGP
Holding Pte. Ltd. (Lian SGP), anak usaha yang sepenuhnya
dimiliki oleh Livzon Pharmaceutical Group Inc. melakukan
penandatanganan Shareholders Agreement (SHA) dalam
rangka pendirian perusahaan patungan;
b. Penandatanganan SHA dilakukan pada tanggal 29
Juli 2024, GCM dan Lian SGP sepakat untuk mendirikan
perusahaan baru bernama PT Livzon Pharma Indonesia yang
berkedudukan di Jakarta Pusat, bergerak di bidang industri
bahan farmasi aktif dengan investasi awal senilai Rp 650
miliar, serta komposisi modal ditempatkan dan disetor penuh
masing-masing sebesar 80% oleh Lian SGP dan 20% oleh
GCM.
Dampak kejadian, informasi atau fakta Kerjasama ini diharapkan dapat memperkuat fokus
material tersebut terhadap kegiatan Perusahaan pada kegiatan produksi bahan aktif farmasi (API)
operasional, hukum, kondisi keuangan, dan bahan farmasi lainnya untuk pasar ekspor, dengan
atau kelangsungan usaha Emiten atau melihat potensi penggunaan pasar domestik di masa
Perusahaan Publik mendatang.
Demikian untuk diketahui.
Hormat Kami,
Enseval Putera Megatrading Tbk
Page 2
Sugianto
Corporate Secretary
Enseval Putera Megatrading Tbk
Jl Pulo Lentut No.10 Kawasan Industri Pulo Gadung, Jakarta 13920
Telepon : (021) 46822422, Fax : (021) 460 9039, www.enseval.com
Nama Pengirim Sugianto
Jabatan Corporate Secretary
Tanggal dan Waktu 30-07-2024 08:37
Lampiran 1. L695 IND.pdf
2. L695 ENG.pdf
Dokumen ini merupakan dokumen resmi Enseval Putera Megatrading Tbk yang tidak memerlukan tanda tangan
karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. Enseval Putera Megatrading Tbk bertanggung
jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. L595/EPMT/CSEC/VII/2024
Issuer Name Enseval Putera Megatrading Tbk
Issuer Code EPMT
Attachment 2
Subject Submission of information regarding the signing of the Shareholders
Agreement (SHA) in order to establish a joint venture company named PT
Livzon Pharma Indonesia.
The company hereby announce the Material Information or Facts Report as follows
Name of Issuer or Public Company Enseval Putera Megatrading Tbk
Business Activities Distributor Produk Kesehatan
Telephone (021) 46822422
Faximile (021) 460 9039
Email Address investor.relations@enseval.com
Date of Event 29 July 2024
Submission of information regarding the signing of the
Type of Material Information or Facts Shareholders Agreement (SHA) in order to establish a joint
venture company named PT Livzon Pharma Indonesia.
Description of Material Information or In order to comply with Financial Services Authority Regulation
Facts No. 31/POJK.04/2015 dated December 16, 2015 concerning
Disclosure of Material Information or Facts by Issuers or Public
Companies, the Company conveys that:
a. The Company through its subsidiary, PT Global
Chemindo Megatrading (GCM) together with Lian SGP
Holding Pte. Ltd. (Lian SGP), a wholly owned subsidiary of
Livzon Pharmaceutical Group Inc. signed a Shareholders
Agreement (SHA) in order to establish a joint venture
company;
b. The signing of the SHA was carried out on July 29,
2024, GCM and Lian SGP agreed to establish a new company
called PT Livzon Pharma Indonesia which is domiciled in
Central Jakarta, engaged in the active pharmaceutical
ingredients industry with an initial investment of IDR 650
billion, and the composition of issued and fully paid capital of
80% by Lian SGP and 20% by GCM, respectively.
Impact of event, material information or This collaboration is expected to strengthen the Company's
facts towards Issuers or Public focus on the production of active pharmaceutical ingredients
Company’s operational activities, legal, (API) and other pharmaceutical ingredients for the export
financial condition, or going concern market, by looking at the potential use of the domestic market
in the future.
Thus to be informed accordingly.
Respectfully,
Enseval Putera Megatrading Tbk
Sugianto
Corporate Secretary
Page 4
Enseval Putera Megatrading Tbk
Jl Pulo Lentut No.10 Kawasan Industri Pulo Gadung, Jakarta 13920
Phone : (021) 46822422, Fax : (021) 460 9039, www.enseval.com
Sender Name Sugianto
Function Corporate Secretary
Date and Time 30-07-2024 08:37
Attachment 1. L695 IND.pdf
2. L695 ENG.pdf
This is an official document of Enseval Putera Megatrading Tbk that does not require a signature as it was
generated electronically by the electronic reporting system. Enseval Putera Megatrading Tbk is fully responsible for
the information contained within this document.
Names mentioned 11 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT Livzon Pharma Indonesia.
p.1 ×4
unresolved
org
PT Livzon Pharma Indonesia. Uraian Informasi
p.1
unresolved
org
PT Global Chemindo Megatrading
p.1 ×2
unresolved
org
Lian SGP Holding Pte. Ltd.
p.1 ×2
unresolved
org
Livzon Pharmaceutical Group Inc.
p.1 ×2
unresolved
org
Sugianto Corporate
p.2
unresolved
org
PT Livzon Pharma Indonesia. Description
p.3
unresolved
org
Financial Services Authority
p.3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.